Search

Your search keyword '"Paroxetine administration & dosage"' showing total 558 results

Search Constraints

Start Over You searched for: Descriptor "Paroxetine administration & dosage" Remove constraint Descriptor: "Paroxetine administration & dosage"
558 results on '"Paroxetine administration & dosage"'

Search Results

1. Paroxetine Loaded Nanostructured Lipid Carriers Based In-situ Gel for Brain Delivery via Nasal Route for Enhanced Anti-Depressant Effect: In Vitro Prospect and In Vivo Efficacy.

2. Optimizing the individual dosing of paroxetine in major depressive disorder with therapeutic drug monitoring.

3. Development and pharmacological evaluation of liposomes and nanocapsules containing paroxetine hydrochloride.

4. Dose adjustment of paroxetine based on CYP2D6 activity score inferred metabolizer status in Chinese Han patients with depressive or anxiety disorders: a prospective study and cross-ethnic meta-analysis.

5. Differences in Cerebral Distribution between Imipramine and Paroxetine via Membrane Transporters at the Rat Blood-Brain Barrier.

6. Physiological tremor is suppressed and force steadiness is enhanced with increased availability of serotonin regardless of muscle fatigue.

7. Effect of Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition vs Placebo in Patients With Anterior Myocardial Infarction: A Randomized Clinical Trial.

8. Antidepressant action of transcranial direct current stimulation in olfactory bulbectomised adolescent rats.

9. Development and evaluation of a physiologically based pharmacokinetic model to predict carvedilol-paroxetine metabolic drug-drug interaction in healthy adults and its extrapolation to virtual chronic heart failure patients for dose optimization.

10. In search of a dose-response relationship in SSRIs-a systematic review, meta-analysis, and network meta-analysis.

11. Comparing Medications for DSM-5 PTSD in Routine VA Practice.

12. Effect of Paroxetine on the Neuropathic Pain: A Molecular Study.

13. Sustaining Circulating Regulatory T Cell Subset Contributes to the Therapeutic Effect of Paroxetine on Mice With Diabetic Cardiomyopathy.

14. Precision dosing-based optimisation of paroxetine during pregnancy for poor and ultrarapid CYP2D6 metabolisers: a virtual clinical trial pharmacokinetics study.

15. Effect of antidepressant drugs on the brain sphingolipid system.

16. Paroxetine for the treatment of intractable and persistent cough in patients diagnosed with cancer.

17. Cardiac autonomic tone, plasma BDNF levels and paroxetine response in newly diagnosed patients of generalised anxiety disorder.

18. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.

19. Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands.

20. Efficacy and safety of lavender essential oil (Silexan) capsules among patients suffering from anxiety disorders: A network meta-analysis.

21. Combination of mirtazapine and paroxetine: possible clinically demonstrated interaction?

22. Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled Trial.

23. Basal Ganglia Calcification: A Case Report of Fahr Disease With Pure Psychiatric Symptoms.

24. Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis.

25. Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials.

26. Pharmacologic chaos: severe hypotension from interactions of anesthetics, marijuana, amphetamines, and paroxetine.

27. Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence.

28. Short-Term Safety of Paroxetine Plus Low-Dose Mirtazapine During Lactation.

29. Ziprasidone Augmentation of SSRI Antidepressants in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Pilot Study of Augmentation Therapy.

30. The effect of paroxetine, venlafaxine and bupropion administration alone and combined on spatial and aversive memory performance in rats.

31. When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips.

32. The impact of CYP2D6 mediated drug-drug interaction: a systematic review on a combination of metoprolol and paroxetine/fluoxetine.

33. Effects of anxiety on suicidal ideation: exploratory analysis of a paroxetine versus bupropion randomized trial.

34. Observational multicenter study of efficacy of paroxetine filmcoated tablet in the treatment of anxiety disorder.

35. Efficacy and Tolerability of Two Different Kinds of Titration of Paroxetine Hydrocloride Solution: an Observational Study.

36. Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial.

37. Benign Migratory Glossitis.

38. Re-evaluation of the definition of remission on the 17-item Hamilton Depression Rating Scale based on recovery in health-related quality of life in an observational post-marketing study.

39. Dextrometorphan-Paroxetine, But Not Dronabinol, Effective for Treatment-Resistant Aggression and Agitation in an Elderly Patient With Lewy Body Dementia.

40. Novel insights into the effect of paroxetine administration in pilocarpine‑induced chronic epileptic rats.

41. Polymorphism in CYP2D6 affects the pharmacokinetics and dose escalation of paroxetine controlled-release tablet in healthy Chinese subjects.

42. Treatment of pruritus in a palliative care patient with low-dose paroxetine: a case report.

43. Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice.

44. Is 18 F-FDG-PET suitable to predict clinical response to the treatment of geriatric depression? A systematic review of PET studies.

45. Randomized controlled trial of repetitive transcranial magnetic stimulation combined with paroxetine for the treatment of patients with first-episode major depressive disorder.

46. The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly.

47. The effects of paroxetine and amitriptyline on the upper esophageal sphincter (UES) pressure and its natural history in globus pharyngeus.

48. Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systems.

49. Single- and multiple-dose pharmacokinetics and tolerability of a paroxetine controlled-release tablet in healthy Chinese subjects
.

50. Effects of paroxetine on intravaginal ejaculatory latency time in Egyptian patients with lifelong premature ejaculation as a function of serotonin transporter polymorphism.

Catalog

Books, media, physical & digital resources